| Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial H Mehanna, M Robinson, A Hartley, A Kong, B Foran, T Fulton-Lieuw, ... The Lancet 393 (10166), 51-60, 2019 | 905 | 2019 |
| Preoperative chemoradiotherapy for rectal cancer: randomized trial comparing oral uracil and tegafur and oral leucovorin vs. intravenous 5-fluorouracil and leucovorin A De La Torre, MI García-Berrocal, F Arias, A Mariño, F Valcárcel, ... International Journal of Radiation Oncology* Biology* Physics 70 (1), 102-110, 2008 | 51 | 2008 |
| High-dose-rate (HDR) plesiotherapy with custom-made moulds for the treatment of non-melanoma skin cancer Á Montero, R Hernanz, AB Capuz, E Fernández, A Hervás, R Colmenares, ... Clinical and Translational Oncology 11, 760-764, 2009 | 33 | 2009 |
| In vitro radiosensitisation by trabectedin in human cancer cell lines J Romero, I Zapata, S Córdoba, JM Jimeno, JA López-Martín, JC Tercero, ... European Journal of Cancer 44 (12), 1726-1733, 2008 | 27 | 2008 |
| Cetuximab versus cisplatin in patients with HPV-positive, low risk oropharyngeal cancer, receiving radical radiotherapy H Mehanna, A Kong, A Hartley, P Mistry, M Dalby, T Fulton-Lieuw, ... Annals of Oncology 29, viii729-viii730, 2018 | 13 | 2018 |
| Centralised RECIST assessment and clinical outcomes with lenvatinib monotherapy in recurrent and metastatic adenoid cystic carcinoma L Feeney, Y Jain, M Beasley, O Donnelly, A Kong, R Moleron, ... Cancers 13 (17), 4336, 2021 | 10 | 2021 |
| A multi-centre survey reveals variations in the standard treatments and treatment modifications for head and neck cancer patients during Covid-19 pandemic I Vasiliadou, D Noble, A Hartley, R Moleron, P Sanghera, TG Urbano, ... Clinical and Translational Radiation Oncology 30, 50-59, 2021 | 5 | 2021 |
| Vinblastine monotherapy induction prior to radiotherapy for patients with intracranial germinoma during the COVID‐19 pandemic MJ Murray, R Moleron, J Adamski, M English, GAA Burke, J Cross, ... Pediatric Blood & Cancer 69 (1), e29359, 2022 | 4 | 2022 |
| Analysis of hydration and antiemetics policies in preventing cisplatin-related gastrointestinal and renal toxicities in low-risk human papillomavirus positive-oropharyngeal … AH Kong, P Mistry, M Evans, AGJ Hartley, T Fulton-Lieuw, D Jones, ... Journal of Clinical Oncology 37 (15_suppl), 6076-6076, 2019 | 2 | 2019 |
| Preoperative chemoradiotherapy for rectal cancer: randomized trial comparing oral Uracil and Tegafur and oral Leucovorin vs. intravenous 5-Fluorouracil and Leucovorin A La Torre, MI Garcia-Berrocal, F Arias, A Marino, F Valcarcel, R Megallon, ... Int J Radiat Oncol Biol Phys 70, 102-110, 2008 | 2 | 2008 |
| The UK Divide: Does having a Pembrolizumab-Chemotherapy option in head and neck cancer matter? Real-world experience of first-line palliative pembrolizumab monotherapy and … A Thapa, A Cowell, A Peters, DJ Noble, A James, C Lamb, D Grose, ... Clinical Oncology, 2024 | 1 | 2024 |
| Simultaneous double laryngeal tumours: a diagnostic and therapeutic challenge F Cooper, R Moleron, A Chapman, M Shakeel BMJ Case Reports CP 14 (2), e239797, 2021 | 1 | 2021 |
| Chemoradiation: Why, what, for whom? R Molerón Reports of Practical Oncology and Radiotherapy 18 (1), 2013 | 1 | 2013 |
| 8724 POSTER Fractionated Stereotactic Radiotherapy (FSRT) for Craniopharyngiomas–Clinical and Radiological Control A Sanz, G Rodriguez, R Moleron, R Magallon, MI Garcia-Berrocal European Journal of Cancer, S582, 2011 | 1 | 2011 |
| Impact of remoteness and rurality on the treatment and survival of patients with glioblastoma in the north of Scotland D Veljanoski, R Barlas, AAB Jamjoom, J Walkden, G Horgan, R Moleron, ... World Neurosurgery: X, 100331, 2024 | | 2024 |
| CompARE: study protocol for a phase III randomised controlled platform trial comparing alternative regimens for escalating treatment of intermediate and high-risk oropharyngeal … H Mehanna, P Gaunt, A Kong, A Hartley, P Sanghera, M Forster, M Sen, ... Trials 25 (1), 50, 2024 | | 2024 |
| 926P UK national real-world outcome data of first-line pembrolizumab treatment in head and neck squamous cell cancer (HNSCC) I Vasiliadou, D Grose, A Hartley, S Partridge, A Haridass, A Williamson, ... Annals of Oncology 34, S584, 2023 | | 2023 |
| PO-1449 Single fraction Lumbopelvic Bone Irradiation with Helical Tomotherapy for metastatic bone disease BG Haro, SS Jiménez, JR Fernández, RM Mancebo, RB Rodríguez, ... Radiotherapy and Oncology 170, S1228-S1229, 2022 | | 2022 |
| PO-1860 Implementation of RTT-led workflow for CBCT-guided online adaptive radiotherapy in head and neck P Darby, J Fox, A Bromiley, C Burnett, N Munn, N Redgwell, J McLellan, ... Radiotherapy and Oncology 170, S1650, 2022 | | 2022 |
| PO-1165 Pattern of recurrence of glioblastoma treated with non-coplanar volumetric modulated arc therapy I Georgiou, P Bhatt, P Bodkin, A Giamouriadis, S Ross, J Walkden, ... Radiotherapy and Oncology 170, S988, 2022 | | 2022 |
